Latest / The Dales Report | Trade to Black
What Canada’s Medical Cannabis Research Means for the U.S.
In this episode of TDR Trade to Black, host Shadd Dales sits down with Avicanna Inc. (TSX: AVCN) CEO Aras Azadian and Dr. Hance Clarke (President, Canadian Pain Society; physician at Toronto General Hospital) to break down a new peer-reviewed medical cannabis study published in the Canadian Journal of Pain.The discussion focuses on a 24-week real-world evidence study that followed patients authorized medical cannabis by healthcare professionals, tracking outcomes across pain, anxiety, sleep, disability, and overall quality of life. The takeaway is clear: results were cautious, clinically…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.